Eskayef (Now Known as Smith Kline Beecham Pharmaceuticals (India) Ltd.) etc. Vs. Commissioner of Income T
With
Civil Appeal Nos. 4545-4547 of 1996
(From the Judgment and Order dated 11.3.91 of the Karnataka High Court in I.T.R.C. No. 182 of 1985)
With
Civil Appeal Nos. 4545-4547 of 1996
(From the Judgment and Order dated 11.3.91 of the Karnataka High Court in I.T.R.C. No. 182 of 1985)
Mr. M.L. Verma, Senior Advocate, Mr. G. Venkatesh Rao and Ms. Sushma Suri, Advocates with him for the Respondent.
Income Tax Act, 1961
Deductions – Surcharge – If an admissible deduction. Held that in view of JT 1996 (4) SC 231, surcharge is not admissible deduction.
(Paras 2 to 5)
Section 37(3A) – Exemption – Samples of prescription drugs – Distribution of physician’s sample to doctors – If expenditure for purpose of business and not subject to restrictions on allow-ability – If does not amount to advertisement or publicity or sales promotion and exempted. Held that distribution amounts to advertisement and promotion of sale and would be subject to limitation as to allowability under Section 37(3A). Case law discussed.
(Paras 8, 11)
2. Commissioner of Income-Tax v. J & J Dechane Laboratories (P) Ltd. ((1996) 222 ITR 11)
3. Commissioner of Income-Tax v. Ampro Food Products, (215 ITR 904)
4. Smith Kline and French (India) Ltd. v. Commissioner of Income-Tax, (193 ITR 582)
Civil Appeal No. 2717 of 1996:
1. The appeal relates to the Assessment Year 1980-81. It is on a certificate of fitness to appeal granted by the High Court. The certification was only in respect of the one question, which read thus:
“Whether on the facts and in the circumstances of the case, the liability to pay surtax is an admissible deduction in computing the total income?”
2. The answer to this question is covered against the assessee by the decision of this Court in the assessee’s own case, 219 I.T.R. 581. The question is, accordingly, answered in the negative and in favour of the Revenue.
3. The civil appeal is dismissed.
4. No order as to costs.
Civil Appeal Nos. 4545-4547 of 1996:
5. These are appeals from the judgment and order of the Division Bench of the Karnataka High Court in Income Tax References. The questions that the High Court was called upon to answer read thus:
“Question of law in ITRC 144 of 1993
(a) Whether on the facts and in the circumstances of the case, the liability to pay surtax is an admissible deduction in comput-ing the total income?
(b) Whether on the facts and in the circumstances of the case, the expenditure incurred on physician’s samples is in the nature of advertisement expenditure falling within the restrictive provisions of Section 37 (3A) of the Income tax Act?
Question of law in ITRC 143 of 1993.
a) Whether on the facts and in the circumstances of the case, the liability to pay surtax is an admissible deduction in computing the total income?
Question of law in ITRC 171 of 1994.
Whether on the facts and in the circumstances of the case, the Tribunal was right in holding that the applicant was not entitled to the deduction of surtax levied while computing the total income of the applicant?”
6. It is common ground that the questions that relate to surtax must be answered in the negative and in favour of the Revenue by reason of the judgment of this Court in the case of Smith Kline and French (India) Ltd. & Ors. v. Commissioner of Income Tax (JT 1996 (4) SC 231 = 219 ITR 581). They are so answered.
7. The issue that is canvassed at the bar relates to the physi-cian’s samples that the assessee, a pharmaceutical company, distributes to the medical profession. It is the assessee’s case that these are all samples of prescription drugs, and we proceed upon that basis. Learned counsel for the assessee submitted that the distribution of physician’s samples to doctors did not amount to advertisement or publicity or sales promotion and, therefore, all the expenditure incurred by the appellants on such distribu-tion was exempt, under the provisions of Section 37 of the In-come-tax Act, 1961 (for short ‘the Act’) as expenditure incurred wholly and exclusively for the purpose of the appellant’s busi-ness, and not subject to the restrictions on allowability con-tained in Sub-section (3A) thereof.
8. The submission did not find favour with the Income-tax Ap-pellate Tribunal and with the High Court. The High Court, in the order under appeal, followed its earlier judgment in the case of Smith Kline and French (India) Ltd. v. Commissioner of Income-Tax, (193 ITR 582), (which also concerned the assessee). The High Court there had said :
“We do not think that we should discuss the principle pertaining to the interpretation of statutes referred to above in detail because the idea behind the contention is to convey that adver-tisement, publicity or sales promotion should be confined to the act of media propaganda and a direct approach to the consumers by publicising the product through newspaper advertisement, posters or some other similar methods. We do not think that such a limit-ed meaning should be given to the three words. The nature of the advertisement or publicity depends upon the nature and quality of the article in question. An inducement to the public to buy a particular commodity may be formulated in a mode most suitable to the article in question.
The members of the public would not buy a drug just because it is advertised repeatedly or publicised through posters or announced on the T.V., etc. The members of the public should have confidence about the curative value of the drug and such con-fidence could be created mainly by the medical practitioners prescribing the said drug or when the medical practitioners give the same to patients towards treatment. The media through which the drug could gets publicised and earn goodwill will be the media of prescription by the medical practitioners. Further, the real persons who could create a market for a particular drug are the medical practitioners themselves having regard to the nature of the drug, when compared to other industrial products. A drug is not an ordinary article of consumption. It is consumed only to get rid of some ailment. Before the drug gets circulated, its reputation will have to be confirmed to the medical practitioners and that is why free samples are supplied to them.
If the object of supplying free samples is only to find out the reaction of the medical practitioners about the efficacy or curative value of the drug, the supply of free samples would have been confined during the initial stages of production of a new drug. However, that is not the case of the assessee here. The assessee nowhere contends that free samples were given to the medical practitioners only at the time when a drug is introduced for the first time.
Learned Counsel for the Revenue also pointed out that the assessee in its original return of income has included these sums under the head “Advertisement, publicity and sales promotion”. Therefore, the assessee’s first impression about the nature of the free samples was the correct approach and the assessee has properly disclosed the same under an appropriate head in the return. Subsequently, the assessee sent a letter modifying the original return of income and offered to confine the claim under this head to a part of the expenditure.
Learned Counsel for the Revenue is justified in pointing out the above circumstances as an additional factor in support of the conclusion arrived at by the Appellate Tribunal.
Each of the three words “advertisement, publicity and sales promotion” cannot always be confined to distinct and different concepts. Some aspects of one word would naturally overlap with the meaning attributed to the other word. No doubt, in a commer-cial sense, the purpose of these activities is to gain goodwill and a market but the mode of achieving this object cannot be confined to the limited meaning attributed to them by learned Counsel for the assessee.”
9. Learned Counsel for the assessee submitted that the physi-cian’s samples were distributed only to doctor and, therefore, the expenditure incurred thereon could not be said to be for advertisement or publicity or sales promotion. He submitted that the purpose of such distribution was to obtain a feedback from the medical profession as to the efficacy of the distributed drugs. As to the first point, we are entirely in agreement with the view taken in the judgment under appeal. Having regard to the fact that these are prescription drugs, the target for any adver-tisement or publicity or sales promotion thereof could only be the doctor who would prescribe them. The object, we have no doubt, of distribution of the samples of the drugs to the doctors is to make them aware that such drugs are available in the market in relation to the cure of a particular affliction and, there-fore, to persuade them to prescribe the same in appropriate cases. So doing is, in our view, tantamount to publicity and sales promotion. Regarding the submission that the distribution of the physician’s samples of the drugs is meant only for obtain-ing feedback from the doctors, we should have thought that the assessee would have backed it up by the production of such feed-back in the form of filled up questionnaires or letters as it might have received from doctors in the past, if any. It is an eloquent answer to the submission that there has been no such production.
10. Learned Counsel for the assessee drew our attention to the provisions of the Drugs and Magic Remedies (Objectionable Adver-tisements) Act, 1954. Section 3 thereof prohibits the publication of any advertisement referring to any drug the terms of which suggest or are calculated to lead to the use of that drug for “(d) the diagnosis, cure, mitigation, treatment or prevention of any disease, disorder or condition specified in the Schedule, or any other disease, disorder or condition……..”. Learned Coun-sel’s submission was that we should not decide in a manner which would lead to the conclusion that the assessee had advertised, by means of physician’s samples, drugs contrary to the prohibition under the Drugs and Magic (Objectionable Advertisements) Act, 1954. We do not read the prohibition therein as applicable to physician’s samples. What is barred thereby is publication, and that is amply clear when one refers to
the definition of “adver-tisement” in that Act.
11. Learned Counsel for the assessee cited the judgment of a Division Bench of the Andhra Pradesh High Court in the case of Commissioner of Income-Tax v. Ampro Food Products, (215 ITR 904). The judgment, substantially, takes the view the Karnataka High Court had taken in the assessee’s case cited above, except that it said, “Expenditure of the nature which is essential to the running of the business-a bare minimum to carry on the trade-would not fall within the meaning of the three expressions, i.e., advertisement, publicity and sales promotion. The other expendi-ture, incurred under any of the three heads, would be within the mischief of the provisions of Sub-section (3A) of Section 37 of the Act and, therefore, will have to be scaled down.” The judg-ment in Ampro Food Products (supra) was followed by the Andhra Pradesh High Court in Commissioner of Income-Tax v. J & J Dechane Laboratories (P) Ltd. ((1996) 222 ITR 11). This was a case that related to physician’s samples. The High Court said:
“In the instant case, the assessee claimed expenditure on distribution of physicians’ samples under Section 37 general head. In view of the principles settled by this Court in the aforesaid decision, if the expenditure falls within the bare minimum it will not be caught by Sub-section (3A) of Section 37, but if it is of the nature which is not essential to the carrying of the business, it will be within the net of Sub-section (3A). Physicians’ samples are necessary to ascertain the efficacy of the medicine and to introduce it in the market for circulation and it is only by this method the purpose is achieved. In such cases giving physicians’ samples for a reasonable period is essential to the business of manufacture and sales of the medi-cine. But if a particular medicine has been introduced into the market and its uses are established, giving of free samples could only be as a measure of sales promotion and advertisement and would thus be hit by Sub-section (3A). As in this case there is a finding of the Commissioner (Appeals) and confirmed by the Trib-unal that the expenditure was incurred to test the efficacy of the drug, the expenditure would be within the ambit of bare minimum to carry on the business. For these reasons, it has to be held that the expenditure on physicians’ samples distributed to doctors is outside the scope of Sub-section (3A) of Section 37 of the Act. Therefore, the appellate authority, as well as the Tribunal are right in directing the exclusion of the expenditure on free samples supplied to the doctors in working out disal-lowance under Section 37(3A) of the Act.”
12. We find it difficult to draw the distinction that the Andhra Pradesh High Court made between expenditure that is essential to the running of the business and other expenditure, all this expenditure being incurred for the same purpose. If all this expenditure on distribution of physicians’ samples is incurred for the purposes of publicity or sales promotion, as we think it is, it falls within the scope of Section 37(3A) of the Act and would be subject to the limitations as to allowability therein contained. Further, it should be noted that in the case of J & J Dechane Laboratories (P) Ltd. (supra), the Commissioner (Appeals) and the Tribunal had found as a fact that some expenditure had been incurred to test the efficacy of the concerned drug. There is no such finding in the case before us.
13. In the result, we are not persuaded to take a view other than that taken by the High Court. The question relating to physi-cian’s samples is, therefore, answered in the affirmative and in favour of the Revenue. The appeals are dismissed with costs.